Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| Autonomix Medical, Inc.AMIX · healthcare | |
|---|---|
| Grade | Nonecomputable_factors_below_threshold: 3 of 14 inputs computable; 7 are required |
| Reliability | 0.76 AUCfailure model, filers with under $12.5M assets; 95% interval 0.65 to 0.86; 63 events, 2020 to 2025 |
| Peer failure rate | 0.60% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | under $12.5M assetstotal assets $7.6M[1] |
| Standard universe | outsiderevenue above $1M and assets above $10M[1-2] |
| Warnings | short runway, thin data, degenerate inputsnot computable: dilution, distress, fortress balance sheet |
| Inputs computable | 3 of 14 |
| Graded from | filings received through Jun 15, 2026116 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $3.102026-10-08; market equity $3.0M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received May 27, 2026; the document on sec.gov.
We are a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Our platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (“RF”) ablation, enabling a “sense, treat, verify” approach intended to improve the precision and consistency of nerve-targeted therapies. The technology we have developed consists of a catheter-based system incorporating a proprietary microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 8.4 | |||||||
| Gross profitability | not computable | 32.2% | |||||
| one or more required annual facts are missing | |||||||
| Return on invested capital | not computable | 9.3% | |||||
| one or more required annual facts are missing | |||||||
| Accruals ratio | (50.9%) | [1,4-6] | (6.6%) | 8.4 | 811 | 2026-03-31 | |
| Gross margin stability, five years | not computable | 2.8 pts | |||||
| five annual gross margins are required; found 0 | |||||||
| Solvency, sleeve percentile 62.6 | |||||||
| Twelve-month failure probability | not computable | 0.07% | |||||
| four consecutive discrete net-income quarters are required; found 4 | |||||||
| Altman Z double-prime | (35.14) | [1,7-12] | (0.31) | 84.1 | 756 | 2026-03-31 | |
| Net debt to EBITDA | not computable | 1.82x | |||||
| one or more required annual facts are missing | |||||||
| Interest coverage | not computable | (4.51x) | |||||
| one or more required annual facts are missing | |||||||
| Current ratio | 4.45x | [7-8] | 2.96x | 41.1 | 839 | 2026-03-31 | |
| Growth and financing | |||||||
| Revenue growth, three-year compound | not computable | 10.0% | |||||
| four annual observations are required; found 3 | |||||||
| Free cash flow growth, three-year compound | not computable | 10.9% | |||||
| four consecutive annual FCF observations are required; found 2 | |||||||
| Reinvestment rate | not computable | 37.1% | |||||
| NOPAT must exceed $100,000 | |||||||
| Asset growth, three years | not computable | 2.1% | |||||
| four annual observations are required; found 3 | |||||||
| Net share issuance, one year | not computable | 2.5% | |||||
| prior share count is 20 days earlier | |||||||
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | (78.7%) | 8.0% | 4 | hotter than 4 of 100 peers |
| Distance from 52-week high | (88.2%) | (31.4%) | 5 | closer to its high than 5 of 100 peers |
| EBIT to enterprise value | (1,643.6%) | (1.5%) | 1 | pricier than 99 of 100 peers |
| Free cash flow yield | (404.4%) | (1.0%) | 3 | pricier than 97 of 100 peers |
| Book value to price | 1.04 | 0.28 | 87 | pricier than 13 of 100 peers |
| Sales to price | 0.00 | 0.31 | 0 | pricier than 100 of 100 peers |
| Composite equity issuance, five years | not computable | 20.3% | a share count from five years earlier is required | |
| Relative strength against the sector, log excess return | (1.76) | (0.14) | 4 | ahead of 4 of 100 peers |
Inputs: market equity $3.0M; EBIT -$17.0M; free cash flow -$12.3M; book equity $3.2M; sales $0; debt $1.5M; cash $3.5M[13].
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2026-03-31 | ||
|---|---|---|
| Return on assets above zero | (170.5%) | ✗ fail[4,6] |
| Operating cash flow above zero | -$12.3M | ✗ fail[5] |
| Return on assets improved | (49.2 pts) | ✗ fail[4,6,14-15] |
| Operating cash flow exceeds net income | $4.4M | ✓ pass[4-5] |
| Long-term leverage fell | n/a[1,6,15] | |
| Current ratio improved | (118.3 pts) | ✗ fail[7-8,16-17] |
| No new shares issued | n/a[18-19] | |
| Gross margin improved | n/a | |
| Asset turnover improved | 0.0 pts | ✗ fail[2,6,15,20] |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $3.5M[3] |
| Operating cash flow, four quarters | -$13.2M[3,5,21-24] |
| Months of runway | 3.1 |
| Late filings, two years | 0 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 57 |
| 10-Q received Aug 13, 2026 | |
| Median daily dollar volume | $625,045 |
| 63 sessions | |
| Days since newest grade input | 116 |
|
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $7.6M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:Revenues | $0 | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 3 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $3.5M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 4 | net income | us-gaap:NetIncomeLoss | -$16.7M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 5 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$12.3M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 6 | assets | us-gaap:Assets | $9.8M | 2025-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 7 | current assets | us-gaap:AssetsCurrent | $7.6M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 8 | current liabilities | us-gaap:LiabilitiesCurrent | $1.7M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 9 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$67.1M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 10 | operating income | us-gaap:OperatingIncomeLoss | -$17.0M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 11 | book equity | us-gaap:StockholdersEquity | $5.9M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 12 | liabilities | us-gaap:Liabilities | $1.7M | 2026-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 13 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 971,043 | 2026-08-06 | 2026-08-13 | 10-Q | filing · viewer · series |
| 14 | net income | us-gaap:NetIncomeLoss | -$11.4M | 2025-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 15 | assets | us-gaap:Assets | $9.4M | 2024-03-31 | 2025-05-29 | 10-K | filing · viewer · series |
| 16 | current assets | us-gaap:AssetsCurrent | $9.6M | 2025-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 17 | current liabilities | us-gaap:LiabilitiesCurrent | $1.7M | 2025-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 18 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 11,409,344 | 2026-06-10 | 2026-06-15 | 10-K/A | filing · viewer · series |
| 19 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 11,409,344 | 2026-05-21 | 2026-05-27 | 10-K | filing · viewer · series |
| 20 | revenue | us-gaap:Revenues | $0 | 2025-03-31 | 2026-05-27 | 10-K | filing · viewer · series |
| 21 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$3.5M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 22 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$9.4M | 2025-12-31 | 2026-02-11 | 10-Q | filing · viewer · series |
| 23 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$6.4M | 2025-09-30 | 2025-11-12 | 10-Q | filing · viewer · series |
| 24 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$2.6M | 2025-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.